High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease
- 31 March 1991
- journal article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 118 (3), 377-382
- https://doi.org/10.1016/s0022-3476(05)82150-x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Hematologic Responses of Patients with Sickle Cell Disease to Treatment with HydroxyureaNew England Journal of Medicine, 1990
- Rapid removal of excessive iron with daily, high-dose intravenous chelation therapyThe Journal of Pediatrics, 1989
- Cerebral infarction in sickle cell anemiaNeurology, 1988
- BONE MARROW TRANSPLANTATION IN FIVE CHILDREN WITH SICKLE CELL ANAEMIAThe Lancet, 1988
- MRI of sickle cell cerebral infarctionNeuroradiology, 1987
- Pediatric digital subtraction angiography: intraarterial and intracardiac applicationsPediatric Radiology, 1986
- Efficacy of transfusion therapy for one to two years in patients with sickle cell disease and cerebrovascular accidentsThe Journal of Pediatrics, 1980
- The natural history of stroke in sickle cell diseaseAmerican Journal Of Medicine, 1978
- Transfusion therapy for cerebrovascular abnormalities in sickle cell diseaseThe Journal of Pediatrics, 1976
- Occlusion of Large Cerebral Vessels in Sickle-Cell AnemiaNew England Journal of Medicine, 1972